Regulation of Selective B Cell Autophagy by the Pro-oxidant Adaptor p66SHC
- PMID: 32274384
- PMCID: PMC7113388
- DOI: 10.3389/fcell.2020.00193
Regulation of Selective B Cell Autophagy by the Pro-oxidant Adaptor p66SHC
Abstract
p66SHC is a pro-oxidant member of the SHC family of protein adaptors that acts as a negative regulator of cell survival. In lymphocytes p66SHC exploits both its adaptor and its reactive oxygen species (ROS)-elevating function to antagonize mitogenic and survival signaling and promote apoptosis. As a result, p66SHC deficiency leads to the abnormal expansion of peripheral T and B cells and lupus-like autoimmunity. Additionally, a defect in p66SHC expression is a hallmark of B cell chronic lymphocytic leukemia, where it contributes to the accumulation of long-lived neoplastic cells. We have recently provided evidence that p66SHC exerts a further layer of control on B cell homeostasis by acting as a new mitochondrial LC3-II receptor to promote the autophagic demise of dysfunctional mitochondria. Here we discuss this finding in the context of the autophagic control of B cell homeostasis, development, and differentiation in health and disease.
Keywords: B lymphocytes; ROS; autophagy; mitophagy; p66SHC.
Copyright © 2020 Onnis, Cassioli, Finetti and Baldari.
Figures



Similar articles
-
The pro-oxidant adaptor p66SHC promotes B cell mitophagy by disrupting mitochondrial integrity and recruiting LC3-II.Autophagy. 2018;14(12):2117-2138. doi: 10.1080/15548627.2018.1505153. Epub 2018 Sep 6. Autophagy. 2018. PMID: 30109811 Free PMC article.
-
P66Shc: A Pleiotropic Regulator of B Cell Trafficking and a Gatekeeper in Chronic Lymphocytic Leukemia.Cancers (Basel). 2020 Apr 19;12(4):1006. doi: 10.3390/cancers12041006. Cancers (Basel). 2020. PMID: 32325830 Free PMC article. Review.
-
p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscape.Haematologica. 2019 Oct;104(10):2040-2052. doi: 10.3324/haematol.2018.209981. Epub 2019 Feb 28. Haematologica. 2019. PMID: 30819907 Free PMC article.
-
Expression of the p66Shc protein adaptor is regulated by the activator of transcription STAT4 in normal and chronic lymphocytic leukemia B cells.Oncotarget. 2016 Aug 30;7(35):57086-57098. doi: 10.18632/oncotarget.10977. Oncotarget. 2016. PMID: 27494881 Free PMC article.
-
p66Shc as a switch in bringing about contrasting responses in cell growth: implications on cell proliferation and apoptosis.Mol Cancer. 2015 Apr 8;14:76. doi: 10.1186/s12943-015-0354-9. Mol Cancer. 2015. PMID: 25890053 Free PMC article. Review.
Cited by
-
STEAP3 can predict the prognosis and shape the tumor microenvironment of clear cell renal cell carcinoma.BMC Cancer. 2022 Nov 23;22(1):1204. doi: 10.1186/s12885-022-10313-z. BMC Cancer. 2022. PMID: 36424540 Free PMC article.
-
Oxidative Stress in Cancer Immunotherapy: Molecular Mechanisms and Potential Applications.Antioxidants (Basel). 2022 Apr 27;11(5):853. doi: 10.3390/antiox11050853. Antioxidants (Basel). 2022. PMID: 35624717 Free PMC article. Review.
-
Role of reactive oxygen species in tumors based on the 'seed and soil' theory: A complex interaction (Review).Oncol Rep. 2021 Sep;46(3):208. doi: 10.3892/or.2021.8159. Epub 2021 Jul 30. Oncol Rep. 2021. PMID: 34328200 Free PMC article. Review.
-
Roles of Reactive Oxygen Species in Biological Behaviors of Prostate Cancer.Biomed Res Int. 2020 Sep 29;2020:1269624. doi: 10.1155/2020/1269624. eCollection 2020. Biomed Res Int. 2020. PMID: 33062666 Free PMC article. Review.
-
The Role of p66Shc in Cancer: Molecular Mechanisms and Therapeutic Implications.J Cell Mol Med. 2025 Jul;29(14):e70737. doi: 10.1111/jcmm.70737. J Cell Mol Med. 2025. PMID: 40690563 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous